Uromed is a company that makes a product called the "Reliance Insert".
Similar to a tampon in its use, a small balloon stops urine flow, it is designed to control stress incontinence in women. The market is huge (8.5 million in U.S.A. alone) for this product, it is an under-reported problem in women. The company is already selling the insert in Europe, and is awaiting FDA approval in the U.S. It has been a huge success in Europe, signing marketing deals with large well known European companies.
Clinical studies found that:
The Reliance Insert effectively controlled urine loss in 97% of patients.
Patients responding to a 12-month questionnaire reported positive results... 90% experienced quality of life improvements
97% would strongly recommend the Reliance Insert to another female incontinence sufferer
URMD earlier this month had 2 glowing reports from members of the American Urological Association, when they met in Orlando FL on May 8th.
I bought at 10 late last year, if I had more to invest I would buy more. I think FDA approval is just a matter of time. How about 30+ by the end of the year... what do you think? |
